GlassScriptPhysician profile
Isabel Denis
NPI 1568905537
$3,680.96
in general payments reported to CMS, 2019-2025
38 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,291 · 2022: $888 · 2023: $1,172 · 2024: $164 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,108.62 | 2021-2024 | |
| Novo Nordisk INC | $303.50 | 2021-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $190.63 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $141.95 | 2022 | |
| Glaxosmithkline, LLC. | $136.56 | 2022-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $132.66 | 2021-2025 | Gardasil 9, Capvaxive, Pneumovax 23 |
| Amgen INC. | $122.64 | 2021-2023 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $119.48 | 2022-2023 | Xarelto |
| Amarin Pharma, INC. | $115.40 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.10 | 2021-2023 | Trintellix |
| Daiichi Sankyo INC. | $103.76 | 2021-2022 | |
| Abbott Laboratories | $96.78 | 2022-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $92.86 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $87.72 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $80.89 | 2022-2024 | Veozah |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Denis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.